NCT01013597 2019-11-29
Trial of LBH589 in Metastatic Thyroid Cancer
University of Wisconsin, Madison
Phase 2 Completed
Clinical Trials
3 trialsNCT00670553 2017-05-17
A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer
Novartis
Phase 1 Completed
NCT00738751 2015-02-04
Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed